Understanding metabolic reprogramming in tumor microenvironment

Editorial

. 2022 Feb 14;1(2):111-113.

doi: 10.1515/mr-2021-0037. eCollection 2021 Dec.

Affiliations

¹ Peking University International Cancer Institute, Beijing, China.
² Department of Biochemistry and Molecular Biology, and Institute of Bioinformatics, University of Georgia, Athens, GA, USA.

Editorial

Shaokun Shu et al. Med Rev (2021). 2022.

. 2022 Feb 14;1(2):111-113.

doi: 10.1515/mr-2021-0037. eCollection 2021 Dec.

¹ Peking University International Cancer Institute, Beijing, China.
² Department of Biochemistry and Molecular Biology, and Institute of Bioinformatics, University of Georgia, Athens, GA, USA.

No abstract available

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. doi: 10.3322/caac.21660. - DOI - PubMed
1. Duan Q, Zhang H, Zheng J, Zhang L. Turning cold into hot: firing up the tumor microenvironment. Trends Cancer. 2020;6:605–18. doi: 10.1016/j.trecan.2020.02.022. - DOI - PubMed
1. Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541–50. doi: 10.1038/s41591-018-0014-x. - DOI - PMC - PubMed
1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed
1. Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metabol. 2016;23:27–47. doi: 10.1016/j.cmet.2015.12.006. - DOI - PMC - PubMed